Notify me when Quang X. Pham files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CVKD | Cadrenal Therapeutics, Inc. | Common Stock, $0.001 par value per share | 24% | $6,315,630 | 421,042 | Quang X. Pham | 23 Jan 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|